In May, CellBio Scientific, a premier provider of life science tools, research services, and clinical solutions, announced the acquisition of BioChain, a leading provider of biospecimen collection, preparation, and analysis. The acquisition strengthens CellBio Scientific's platform at a pivotal moment in drug discovery and development, as the industry focuses on using human-relevant research models and analyses. The combined platform will be well-positioned to meet growing demand for innovative tools and translational research solutions. Learn More.

CellBio Scientific is a premier provider of life science tools, research services, and clinical solutions advancing the frontiers of biomedical discovery. Formed through the strategic integration of System Biosciences (SBI), Acepix Biosciences and BioChain, the company offers a comprehensive portfolio spanning biospecimens, spatial biology, extracellular vesicle technologies, gene delivery systems, cell-based models, and preclinical and clinical histopathology services. With a deep commitment to scientific excellence and innovation, CellBio Scientific empowers researchers, biopharma partners, and clinicians to drive breakthroughs in human health. Learn More.